NDC 43378-122 - Zodryl DEC 35
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43378-122
- Package NDCs from labels
- 43378-122-04
- Manufacturer
- CodaDose, Inc. | Gorbec Pharmaceutical Services Inc.
- Effective date
- 2009-09-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zodryl DEC 35 - CodaDose, Inc. | Gorbec Pharmaceutical Services Inc. | CodaDose, Inc. | Gorbec Pharmaceutical Services Inc. | 2009-09-11 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43378-122-04 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d845-621f-e053-dbdaa90a74ad | ZODRYL DEC 35 - codeine phosphate, guaifenesin and pseudoephedrine hydrochloride suspension |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43378-122-04 | Zodryl DEC 35 | 118 mL in 1 BOTTLE, PLASTIC | SUSPENSION | 118 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43378-122-04 | ML - Milliliter | 43378-122 | b282f40b-1804-4344-a1cd-cb4962b51c72 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | Bryant Ranch Prepack | 9f2127d9-d60b-42d3-9b6c-798e63dd68d1 | 2024-08-09 | Boxed warning, Warnings, Adverse reactions | GSL05Y1MN6 |
| Up and Up Hemorrhoid MAX STRENGTH | 14.4% GLYCERIN, 0.25% PHENYLEPHRINE HCL, 1% PRAMOXINE HCL, 15% PETROLATUM | Target Corporation | 867677b5-fd1d-449e-966e-1de0b5c98afb | 2024-08-08 | Warnings | PDC6A3C0OX |
| Mucus Relief Sinus Severe Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 2f2a2864-af11-4240-bdad-a54aca58d01b | 2024-08-07 | Warnings | 495W7451VQ |
| Cold plus Flu Congestion Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 0199aea2-a9c1-4c9d-8786-28b9dadc832e | 2024-08-07 | Warnings | 495W7451VQ |
| Mucus Relief Cold Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 32d1ce6e-2617-4b50-a9e6-2e1941465dff | 2024-08-07 | Warnings | 495W7451VQ |
| Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 07362db5-a372-4463-af8b-06e8783ca865 | 2024-08-07 | Warnings | 495W7451VQ |
| Head Congestion plus Flu Severe PE | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 1fb11d90-48bf-4baa-9b3a-5d64d81e3a06 | 2024-08-07 | Warnings | 495W7451VQ |
| Mucus Relief Sinus Pressure Pain and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 574774b2-9813-4799-9cd4-27e296dd8584 | 2024-08-07 | Warnings | 495W7451VQ |
| Head Congestion plus Mucus PE | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 990f3232-bc75-45cf-8a50-cd7861d83f98 | 2024-08-07 | Warnings | 495W7451VQ |
| Mucus Relief Cold and Flu All in One | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 0f5f25c6-7389-4285-b8d5-463cb7b6fcc4 | 2024-08-07 | Warnings | 495W7451VQ |
| Mucus Relief | GUAIFENESIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 1445433b-69bc-487c-aa5a-e4ac7f5bef21 | 2024-08-07 | Warnings | 495W7451VQ |
| Guaifenesin DM | GUAIFENESIN AND DEXTROMETHORPHAN | American Health Packaging | 8632a655-7f5b-450f-95fa-62478a174e9c | 2024-08-04 | Warnings | 495W7451VQ |
| Guaifenesin DM | GUAIFENESIN AND DEXTROMETHORPHAN | American Health Packaging | 990906b3-c566-4f35-923c-060202ba48e0 | 2024-08-04 | Warnings | 495W7451VQ |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | H E B | 20df2ffe-5281-4cd6-adb3-3a3d28788ef6 | 2024-08-02 | Warnings | 495W7451VQ |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | H E B | bcc41783-9213-4a8e-b7db-75b4da08551d | 2024-08-02 | Warnings | 495W7451VQ |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | H E B | 187097bf-37c8-4184-a2fd-1eff9147d370 | 2024-08-01 | Warnings | 495W7451VQ |
| Guaifenesin 600 mg | GUAIFENESIN | Dr. Reddy's Laboratories Inc. | 99307c61-5df3-0a83-1e21-ddb03bc905b4 | 2024-07-26 | Warnings | 495W7451VQ |
| Mucinex | GUAIFENESIN | American Health Packaging | 0129f47d-abc2-414c-b4e1-1064c5d6a623 | 2024-07-25 | Warnings | 495W7451VQ |
| Pseudoephedrine HCl | PSEUDOEPHEDRINE HCL | Better Living Brands LLC | f9d5a22a-3964-08b8-e053-6294a90ab220 | 2024-07-24 | Warnings | 6V9V2RYJ8N |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | ACETAMINOPHEN AND CODEINE PHOSPHATE | NuCare Pharmaceuticals, Inc. | 1e01f923-38c1-9b59-e063-6394a90a22f1 | 2024-07-24 | Boxed warning, Warnings, Adverse reactions | GSL05Y1MN6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.